24 May 2013
Keywords: Bristol-Myers Squibb, Innate Pharma, Cancer antibody, IPH2102, Licensing
Article | 07 July 2011
US drug major Bristol-Myers Squibb (NYSE: BMY) has signed a global agreement with French biotech firm Innate Pharma (Euronext Paris: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 July 2011
8 July 2011
23 May 2013
© 2013 thepharmaletter.com